TScan Therapeutics (TCRX) FCF Margin (QoQ) (2020 - 2026)
TScan Therapeutics (TCRX) FCF Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | TScan Therapeutics | 100.59 Mn | -27.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -123,462.00 |
| Dec 31, 2025 | 1,307.00 |
| Sep 30, 2025 | -19,612.00 |
| Jun 30, 2025 | 73,998.00 |
| Mar 31, 2025 | 245,380.00 |
| Dec 31, 2024 | -146,365.00 |
| Sep 30, 2024 | 226,155.00 |
| Jun 30, 2024 | 24,186.00 |
| Mar 31, 2024 | -496,641.00 |
| Dec 31, 2023 | -52,866.00 |
| Sep 30, 2023 | 90,122.00 |
| Jun 30, 2023 | -29,447.00 |
| Mar 31, 2023 | 10,606.00 |
| Dec 31, 2022 | -6,266.00 |
| Sep 30, 2022 | -7,426.00 |
| Jun 30, 2022 | 30,748.00 |
| Mar 31, 2022 | -10,239.00 |
| Dec 31, 2021 | 28,895.00 |
| Sep 30, 2021 | -54,577.00 |
| Jun 30, 2021 | 25,734.00 |